IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $148,898,000 | +36.0% | 1,748,127 | -43.4% | 0.06% | +29.8% |
| Q2 2020 | $109,518,000 | +56.4% | 3,090,173 | -40.5% | 0.05% | +27.0% |
| Q1 2020 | $70,044,000 | -23.8% | 5,196,524 | +19.6% | 0.04% | -2.6% |
| Q4 2019 | $91,918,000 | +201.7% | 4,344,203 | +89.2% | 0.04% | +171.4% |
| Q3 2019 | $30,466,000 | +8.4% | 2,296,490 | +13.3% | 0.01% | +7.7% |
| Q2 2019 | $28,112,000 | -7.0% | 2,026,891 | +28.8% | 0.01% | -7.1% |
| Q1 2019 | $30,225,000 | +71.5% | 1,573,388 | +27.5% | 0.01% | +55.6% |
| Q4 2018 | $17,622,000 | -22.4% | 1,234,273 | +13.3% | 0.01% | +12.5% |
| Q3 2018 | $22,700,000 | -9.2% | 1,089,837 | +3.2% | 0.01% | -27.3% |
| Q2 2018 | $24,992,000 | +39.4% | 1,056,162 | -14.0% | 0.01% | +37.5% |
| Q1 2018 | $17,934,000 | +84.8% | 1,227,716 | +104.4% | 0.01% | +100.0% |
| Q4 2017 | $9,706,000 | +18.8% | 600,639 | +2.8% | 0.00% | 0.0% |
| Q3 2017 | $8,169,000 | +14.1% | 584,308 | -27.9% | 0.00% | 0.0% |
| Q2 2017 | $7,161,000 | +316.1% | 810,737 | +204.5% | 0.00% | +300.0% |
| Q1 2017 | $1,721,000 | +17110.0% | 266,233 | +10155.5% | 0.00% | – |
| Q3 2014 | $10,000 | 0.0% | 2,596 | -0.4% | 0.00% | – |
| Q2 2014 | $10,000 | -16.7% | 2,606 | -4.4% | 0.00% | – |
| Q1 2014 | $12,000 | +50.0% | 2,726 | +65.1% | 0.00% | – |
| Q4 2013 | $8,000 | -78.9% | 1,651 | -73.4% | 0.00% | – |
| Q3 2013 | $38,000 | +15.2% | 6,211 | +2.0% | 0.00% | – |
| Q2 2013 | $33,000 | – | 6,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|